Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants
View/Open
Author
Publication date
2025-06-30ISSN
0146-6615
Abstract
SARS‐CoV‐2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which
exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region
near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the
dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and
adaptation of Omicron in the human population, a deep‐sequencing study was performed in RNA samples of BA.1, BA.1.1,
BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary
patterns within SARS‐CoV‐2 characterized by a shift from a significant to a very low production of DVGs. This event suggests
that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans.
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
619 - Veterinary science
Pages
13
Publisher
Wiley
Is part of
Journal of Medical Virology
Recommended citation
Campos, Carolina, Marta Ibañez‐Lligoña, Sergi Colomer‑Castell, Josep Gregori, Damir Garcia‑Cehic, Cristina Andrés, Maria Piñana, Júlia Vergara, et al. 2025. “Deep Sequencing Reveals Dual Evolution of SARS‐CoV‐2: Insights Into Defective Genomes From Wuhan‐Hu‐1 Variants to Omicron Subvariants.” Journal of Medical Virology 97 (7). https://doi.org/10.1002/jmv.70476.
Grant agreement number
MICINN/Programa Estatal para impulsar la investigación científico-técnica y su transferencia/PID2021‐126447OB‐I00/ES/Estrategias de terapia génica para controlar la infección por los virus de la hepatitis B y Delta basada en el estudio de las cuasiespecies virales por secuenciación masiva/
ISCIII/Programa Estatal de I+D+I orientada a los retos de la sociedad/PI19-00533/ES/Cambios dinámicos en la respuesta inmunitaria específica de VHC durante y después del tratamiento con DAAS para desentrañar nuevos enfoques para el desarrollo de vacunas profilácticas/
FEDER/ / /EU/ /
CIBER/ / /ES/ /
CDTI/IDI-20200297/ES/ / /
Program
Sanitat Animal
This item appears in the following Collection(s)
- ARTICLES CIENTÍFICS [3467]
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/


